ACRS Insider Trading Activity and SEC Form 4 Filings
ACRS insider trading summary
Over the past 12 months, insiders at Aclaris Therapeutics, Inc. (ACRS) reported 1 sale worth $1.4M by 1 insider and no open-market purchases on SEC Form 4. Net insider selling was $1.4M.
Latest ACRS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 23, 2026 | Braden Michael Leonard | Insider | Sell | $1.4M (300,000 @ $4.53) |
| Nov 19, 2024 | Anand Mehra | Insider | Buy | $1.5M (666,666 @ $2.25) |
| Aug 5, 2024 | Braden Michael Leonard | Insider | Buy | $256K (206,025 @ $1.24) |
| Aug 2, 2024 | Braden Michael Leonard | Insider | Buy | $216K (167,544 @ $1.29) |
| Jul 31, 2024 | Braden Michael Leonard | Insider | Buy | $133K (100,000 @ $1.33) |
| Jul 30, 2024 | Braden Michael Leonard | Insider | Buy | $226K (173,730 @ $1.30) |
| Jul 22, 2024 | Braden Michael Leonard | Insider | Buy | $24K (17,716 @ $1.33) |
| Jul 19, 2024 | Braden Michael Leonard | Insider | Buy | $9K (6,689 @ $1.30) |
| Jul 18, 2024 | Braden Michael Leonard | Insider | Buy | $170K (130,317 @ $1.30) |
| Jul 5, 2024 | Braden Michael Leonard | Insider | Buy | $141K (123,017 @ $1.15) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.